<DOC>
	<DOCNO>NCT00926068</DOCNO>
	<brief_summary>A prospective , double blind , randomize , placebo control , outpatient , parallel group comparison trial ass safety efficacy HO/03/03 10µg versus Placebo , apply topically daily 14 week least 196 subject diagnose Diabetes Mellitus single target non-healing Plantar Neuropathic Diabetic Foot Ulcer .</brief_summary>
	<brief_title>Safety Efficacy HO/03/03 10μg Treatment Plantar Neuropathic Diabetic Foot Ulcers</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Diabetic Foot</mesh_term>
	<mesh_term>Foot Ulcer</mesh_term>
	<criteria>1 . Age 18 80 year , extremes include 2 . Diagnosed Diabetes Mellitus Type 1 Type 2 3 . Having document single target nonhealing Plantar Neuropathic Diabetic Foot Ulcer minimal duration 4 week prior inform consent signature 4 . Ulcer size randomization : Wagner grade 1 , 2.0 cm2 10 cm2 , extremes include ; Wagner grade 2 , 1.0 cm2 10 cm2 , extremes include ; 5 . Single target , ulcer study foot : Wagner grade 1 ; Wagner grade 2 ( involve abscess osteomyelitis ) ; 6 . Target ulcer area decrease ≤ 30 % OR ≤ 0.1 cm/wk edge heal rate measure debridement screen debridement clinically indicated randomization . 7 . Glycosylated Haemoglobin A1c ( HbA1c ) ≤ 12 % ; 8 . Ankle Brachial Index ( ABI ) study foot : 0.7 ≤ ABI ≤ 1.2 ABI &gt; 1.2 toe pressure &gt; 50 mm Hg ( ABI measure Doppler ; toe blood pressure measure toe cuff ) ; 9 . Diabetic Neuropathy confirm neurological test 10 . Subject available entire study period , able willing adhere protocol requirement 11 . Subject sign informed consent form prior study protocol related procedure Subjects meet one follow criterion select : 1 . Anamnesis current recent past ( within last 2 year ) abuse alcohol , barbiturate , benzodiazepine , amphetamine , narcotic , cocaine , psychoactive drug abuse substance interfere treatment compliance 2 . Use growth factor , skin graft participation investigational study within last 30 day prior begin screen period 3 . Females pregnant , lactating , childbearing potential , postmenopausal less 2 year use medically approve method contraception female test positive bloodbased pregnancy test 4 . Have document medical history HIV , HBV HCV 5 . Have document medical history significant cardiac , pulmonary , gastrointestinal , endocrine ( Diabetes Mellitus type 1 2 ) , metabolic , neurological , hepatic nephrologic disease and/or receive dialysis 6 . Anaemia ( Haemoglobin &lt; 9 gram/dL female Haemoglobin &lt; 10 gram/dL male ) White Blood Cells count &gt; 11,000/μL Platelets count &lt; 100,000/μL impaired renal function ( Creatinine &gt; 3 mg/dL ) liver function test &gt; 3 time upper normal lab value indication malnourishment ( Albumin &lt; 2.8 g/dL ) clinically significant biochemistry , haematology urinalysis test ; 7 . Had clinically significant illness last 4 week prior screen period ; 8 . Have current malignancy past malignancy last 5 year Basal Cell Carcinoma treat radio/chemotherapy 9 . Have sign clinical infection wound ( could link raise body temperature , abscess , osteomyelitis , necrosis erythema ) 10 . Had antibiotic treatment screen period ; 11 . Had evidence infection osteomyelitis plain foot xray screening ; 12 . Is bedridden unable come clinic ; 13 . Have one target nonhealing Diabetic Foot Ulcer per subject ; 14 . Plantar Neuropathic DFU locate active Charcot foot ; 15 . Have hind foot ulcer foot deformity/condition prevent use offload footwear ; 16 . Had leg revascularization surgery within last 6 month candidate revascularization surgery course study ; 17 . Glucocorticosteroid treatment ( Prednisone &gt; 10 mg/day equivalent ) 18 . Inability stop alternative wound heal treatment ( e.g . Becaplermin topical product ) follow debridement</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2013</verification_date>
	<keyword>Diabetes Mellitus</keyword>
	<keyword>Foot Ulcer</keyword>
	<keyword>DFU</keyword>
	<keyword>Wound heal</keyword>
</DOC>